Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease

[Display omitted] We report the discovery of a novel series of influenza Cap-dependent EndoNuclease (CEN) inhibitors based on the 4-pyridone-carboxylic acid (PYXA) scaffold, which were found from our chelate library. Our SAR research revealed the lipophilic domain to be the key to CEN inhibition. In...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 26; no. 19; pp. 4739 - 4742
Main Authors Miyagawa, Masayoshi, Akiyama, Toshiyuki, Mikamiyama-Iwata, Minako, Hattori, Kazunari, Kurihara, Naoko, Taoda, Yoshiyuki, Takahashi-Kageyama, Chika, Kurose, Noriyuki, Mikamiyama, Hidenori, Suzuki, Naoyuki, Takaya, Kenji, Tomita, Kenji, Matsuo, Kenji, Morimoto, Kenji, Yoshida, Ryu, Shishido, Takao, Yoshinaga, Tomokazu, Sato, Akihiko, Kawai, Makoto
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 01.10.2016
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] We report the discovery of a novel series of influenza Cap-dependent EndoNuclease (CEN) inhibitors based on the 4-pyridone-carboxylic acid (PYXA) scaffold, which were found from our chelate library. Our SAR research revealed the lipophilic domain to be the key to CEN inhibition. In particular, the position between the chelate and the lipophilic domain in the derivatives was essential for enhancing the potency. Our study, based on virtual modeling, led to the identification of 2y as a potent CEN inhibitor with an IC50 of 5.12nM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2016.08.038